CATEGORIES

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine

Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.

Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis

US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.

Singapore designs novel gene therapy offering hope for epilepsy patients

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.

Spider venom heart drug moves to clinical trials in Australia

A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).

India develops portable ultrasound scanner for sports injury diagnosis

A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.

Integris appoints medtech veteran Probir Das as new CEO

Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.

Clarity Pharma promotes Michelle Parker to CEO

Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.

Dr Makoto Sugita steps in as President of Nxera Pharma Japan

Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.

Victor Ambros and Gary Ruvkun win 2024 Nobel Prize in Physiology or Medicine for discovery of microRNA

The Nobel Assembly at Karolinska Institutet has decided to award the 2024 Nobel Prize in Physiology or Medicine jointly to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Nobel Prize in Chemistry 2024 to trio for cracking code for protein structures

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024, with one half to David Baker, University of Washington, US for computational protein design; and the other half jointly to Demis Hassabis, Google DeepMind, London, UK; and John M. Jumper, Google DeepMind, London, UK for protein structure prediction.

University of Hong Kong to establish Global Innovation Centre

To consolidate Hong Kong's leading position in basic research, the University of Hong Kong (HKU) is planning to establish the Global Innovation Centre (GIC), an upstream technology research facility, in Pokfulam.

National University of Singapore and Imperial College London establish major research partnership

National University of Singapore (NUS) and Imperial College London have announced a new partnership to strengthen research collaborations.

Managing Delicate Role of Donors for Drug Development and Research

A sustainable, active, and diverse donor pool is more important than ever as the frontiers of medical research continue to push the envelope.

"The Vietnam Institute is set to play a key role in fostering regional collaborations as a hub for knowledge exchange & partnerships"

The University of Sydney Vietnam Institute, officially launched in June 2024, aims to enhance Vietnam’s scientific capacity and contribute to the country’s economic and social development.

"Australia is a great place to do business as we have a superb research community, great partners and very experienced clinical trial units"

Noxopharm Limited, an Australian biotech company, is making strides in the fight against cancer and inflammation with its innovative technology platforms, Chroma and Sofra.

"Moving forward, cancer may not be a death threat but a manageable disease with strong control"

Cartherics Pty Ltd, a Melbourne-based biotechnology company led by renowned stem cell biologist and IVF pioneer Prof Alan Trounson, is , focusing on a portfolio of CAR-T and CAR-NK cell products.

"To achieve our 'Skilled India' vision, we'll train a large number of individuals quickly and to high standards"

Jayant Singh Chaudhary, Union Minister of State (Independent Charge), Skill Development and Entrepreneurship, Government of India, in an interaction with BioSpecturm in Hyderabad, shares his insights on the various initiatives taken up by the Centre for skill development programmes, boosting self-employment.

Targeted Transformation of Diabetes Care in India

According to the International Diabetes Federation (IDF) about 63 per cent of people with diabetes say that the fear of developing diabetes-related complications affects their well-being.

Digital Innovations in Diabetes Care

Diabetes affects 537 million people globally and is a major contributor to the non-communicable disease NCD) epidemic. Technological tools such as continuous glucose monitors CGMs) and mobile apps are redefining diabetes management. On this World Diabetes Day November 14, 2024), we explore how digital health is transforming diabetes care and the challenges associated with its integration into healthcare systems.

APAC Bullish on Biosupplier Revenue by Jan Amidst Global Uncertainty

The Asia-Pacific (APAC) market plays a crucial role for global biosupplier companies, contributing anywhere from 15 per cent to 25 per cent of their total global revenues.

WHO adds HPV vaccine for single-dose use

The World Health Organisation (WHO) has announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin (developed by Xiamen Innovax Biotech) has been confirmed for use in a single-dose schedule.

WHO and multilateral development banks kick off $1.5 B primary health financing platform

Execution is starting under the new Health Impact Investment Platform on the first country health investment plans turning original commitment into operational reality.

Mediwhale secures $12 M to enhance cardiovascular and metabolic disease management

Mediwhale, an artificial intelligence (AI)-powered health diagnostics startup based in South Korea, has announced $12 million series A2 investment.

Singapore launches accelerator programme for startups in digital health innovation

The National University of Singapore (NUS) Medicine Digital Advanced Technology Accelerator (DATA) has launched its Digital Accelerator Programme for startups in the field of digital health innovation.

Alpha Fusion accelerates astatine-based drug discovery with Series B funding

Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technology Agency (JST) OPERA QISS programme, has raised a total of ¥1.02 billion through a Series B funding round.

India-Australia partnership to build bio innovation corridor

La Trobe University, Australia and India's Biotechnology Industry Research Assistance Council (BIRAC) have signed a Letter of Intent (LOI) to establish a Bio Innovation Corridor to support the development of research and innovation.

Taiwan's Pharmosa Biopharm expands collaboration with Liquida

Liquidia Corporation, a US-based biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, and Taiwan-based Pharmosa Biopharm have amended the current exclusive licensing agreement for the development and commercialisation of L606, an inhaled, sustained-release formulation of treprostinil currently being evaluated in a clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Sunway Healthcare Group inks MoU with Medtronic to advance medical care in Malaysia

Sunway Healthcare Group from Malaysia and Medtronic have officially signed a Memorandum of Understanding (MoU), marking a significant milestone in their collaborative journey to advance medical care, and underscoring a shared vision of developing solutions to tackle some of the most pressing healthcare challenges.